COVID-19, Flu, RSV Vaccine Coverage Low for Adults in 2024 to 2025 Season
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 25, 2024 -- COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025), according to research published in the Nov. 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Jennifer L. Kriss, Ph.D., from the CDC in Atlanta, and colleagues used data from the National Immunization Survey-Adult COVID Module for U.S. adults aged 18 years and older to monitor influenza, COVID-19, and RSV vaccination coverage.
The researchers found that an estimated 34.7 percent of adults reported having received an influenza vaccine by the week ending Nov. 9, 2024; 17.9 percent reported having received a COVID-19 vaccine for the 2024 to 2025 respiratory virus season; and 39.7 and 31.6 percent of adults aged 75 years and older and 60 to 74 years, respectively, with an increased risk for severe RSV had ever received an RSV vaccine. There was variation seen in coverage by jurisdiction and demographic characteristics, with younger adults and those without health insurance having the lowest coverage. Many adults seemed open to vaccination, with about 35 and 41 percent reporting that they definitely or probably will receive or were unsure about receiving influenza and COVID-19 vaccines, respectively; among those 75 years and older, 40 percent reported that they definitely or probably will receive or are unsure about receiving the RSV vaccine.
"Health care providers and immunization programs still have time to expand outreach and promote vaccination activities to improve vaccination coverage, especially before persons gather with friends and family during the winter holidays," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Public Awareness Low About HPV, HPV Vaccination, HPV-Linked Cancer
THURSDAY, Aug. 14, 2025 -- Public awareness about human papillomavirus (HPV), HPV vaccination, and HPV-associated cancers is low, according to a research letter published online...
Many Not Up to Date With Vaccines Would Accept Shots During ED Visits
MONDAY, Aug. 11, 2025 -- Many individuals who are not up to date with recommended vaccinations would accept vaccines if offered during an emergency department visit, according to...
Oseltamivir for Flu Tied to Reduced Risk for Serious Neuropsychiatric Events in Children
THURSDAY, Aug. 7, 2025 -- Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.